Pembrolizumab (anti-PD-1)
Pembrolizumab (anti-PD-1) is a potent, highly selective, fully humanized immunoglobulin (Ig) G4-kappa monoclonal antibody against PD-1 with potential immune checkpoint inhibitory and antineoplastic activities. MW : 146.286 KD.
| Trivial name | MK-3475, lambrolizumab |
| Catalog Number | A2005 |
| CAS# | 1374853-91-4 |
| Size | 1mg |
| Supplier Page | http://www.selleckchem.com/products/pembrolizumab.html |
| Additional Information | https://file.selleck.cn/downloads/struct/nivolumab-chemical-structure-a2002.gif |